Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122483 · ClinicalTrials.gov registry record
Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 250
- Enrollment target
NCT03122483 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 250 participants.
The verdict
NCT03122483 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.
Interventions
- DIAGNOSTIC_TEST blood biomarker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-07-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03122483
The ClinicalTrials.gov registry entry for NCT03122483 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beckman Coulter, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blood biomarker is the first listed.
NCT03122483 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03122483 about?
NCT03122483 is a clinical study titled "Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)". This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.
What is the current status of trial NCT03122483?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2016-01. Estimated completion is 2017-07-14.
What interventions are being tested in trial NCT03122483?
The interventions under investigation include: blood biomarker (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03122483?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.